why choose us

First received: May 02, 2023

Clinical Trial: Allopurinol Improves Heart Function in African Americans With Resistant Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure Preserved Ejection Fraction

Study Type: INTERVENTIONAL


Official Title: Allopurinol Improves Diastolic Function in African Americans With Resistant Hypertension

Brief Summary: African American adults in the United States have the highest prevalence rate of high blood pressure (hypertension) and heart failure in the world.African Americans with treatment resistant hypertension have higher levels of the enzyme - xanthine oxidase compared to Caucasians.This trial will test if administration of the xanthine oxidase inhibitor - Allopurinol (commonly used in the treatment of gout), given over a period of 8 weeks, will improve heart function, exercise ability and quality of life in African…

Read more